Abstract
Herein, we report to the best of our knowledge the
first 64Cu PET imaging agent that shows appreciable in vivo brain uptake and exhibits high
specific affinity for beta-amyloid (Aβ) aggregates, leading to the successful PET
imaging of amyloid plaques in the brains of 5xFAD mice versus those of WT mice.
The employed approach uses a bifunctional chelator with two Aβ-interacting
fragments that dramatically improves the Aβ-binding affinity and lipophilicity
for favorable BBB penetration, while the use of optimized-length spacers between
the Cu-chelating group and the Aβ-interacting fragments further improves the in vivo Aβ-binding specificity and brain
uptake of the corresponding 64Cu PET imaging agent.
Supplementary materials
Title
SuppInfo
Description
Actions